Toxicity of dioxin: The function of the PAS proteins;Toxicite de la dioxine: Role des proteines PAS

Medecine/Sciences

Volumn 15, Issue 12, 1999, Pages 1379-1387

  Lesca, Pierre ^a   Pineau, Thierry ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIOXIN; ENVIRONMENTAL CHEMICAL; TRANSCRIPTION FACTOR;

ENVIRONMENTAL EXPOSURE; GENE ACTIVATION; REVIEW; SIGNAL TRANSDUCTION; TOXICOLOGY;

EID: 0033371810     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1280     Document Type: Review

References (49)

1. Hornberger E, Reggiani G, Sambeth J, Wipf HK. The Seveso accident: its nature, extent and consequences. Ann Occup Hyg 1979; 22: 327-70.
2. Pohjanvirta R, Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachloro-dibenzo-p-dioxin in laboratory animals: effects, mechanisms and animal models. Pharmacol Rev 1994; 46: 483-549.
3. Nenbert D. Reflections on the assessment of the toxicity of « dioxins »for humans using data from experimental and epidemiological studies. Teratogen Carcinog Mutagen 1997; 17: 157-215.
4. Whysner J, Williams GM. 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation and tumor promotion. Pharmacol Ther 1996; 71: 193-223.
5. Safe S. Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratogen-Carcinog Mutagen 1997 ; 17: 285-304.
6. Nebert DW, Gelboin HV. The in vivo and in vitro inductions of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains and developmental and hormonal states. Arch Biochem Biophys 1969; 134: 76-89.
7. Whitlock JP. Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 1999; 39: 103-25.
8. Manchester DK, Gordon SK, Golas, CL, Roberts EA, Okey AB. Ah receptor in human placenta: stabilization by molybdate and characterization of binding by 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene and benzo(a)pyrene. Cancer Res 1987; 47: 4861-8.
9. Poland A, Glover E, Kende AS. Stereospecific high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 1976; 251: 4936-46.
10. Poland A, Knutson JC. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons : examination of the mechanism of toxicity. Ann Rev Pharmacol Toxicol 1982; 22: 517-54.
11. Pohjanvirta R, Tuomisto J. Han/wistar rats are exceptionnally resistant to TCDD. Arch Toxicol 1987; 11 (suppl): 344-7.
12. Pohjanvirta R, Juvonen R, Kärenlampi S, Raunio H, Tuomisto J. Hepatic Ah receptor levels and the effect of 2,3,7,8-tetrachloro dibenzo-p-dioxin (TCDD) on hepatic microsomal monooxygenase activities in a TCDD-susceptible and -resistant rat strain. Taxicol Appl Pharmacol 1988 ; 92: 131-40.
13. Crosthwaite SK, Dunlap JC, Loros JJ. Neurospora wc-1 and wc-2: transcription, photoresponses, and the origins of circadian rhythmicity. Science 1997; 276: 763-9.
14. Fukunaga BN, Hankinson O. Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding. J Biol Chem 1996 ; 271 : 3743-9.
15. Jain S, Dolwick KM, Schmidt JV, Bradfield CA. Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. J Biol Chem 1994; 269: 31518-24.
16. Schmidt JV, Carver LA, Bradfield CA. Molecular characterization of the murino Ahr gene. Organization, promoter analysis, and chromosomal assignment. J Biol Chem 1993; 268: 22203-9.
17. Gradelet S, Astorg P, Pineau T, et al. Ah receptor-dependent CYPIA induction by two carotenoids, canthaxanthin and beta-apo-8′-carotenal, with no affinity for the TCDD binding site. Biochem Pharmacol 1997; 54: 307-15.
18. Rannug U, Rannug A, Sjoberg U, Li H, Westerholm R, Bergman J. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 1995; 2: 841-55.
19. Pratt WB. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 1997; 37: 297-326.
20. Coumailleau P, Poellinger I., Guistafsson JA, Whitelaw ML. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J Biol Chem 1995; 270: 25291-300.
21. Antonsson C, Whitelaw ML, McGuire J, Gustafsson JA, Poellinger L. Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains. Mol Cell Biol 1995; 15: 756-65.
22. Carver LA, Bradfield CA. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in viva. J Biol Chem 1997; 272: 11452-6.
23. Ma Q, Whitlock JP Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 1997; 272: 8878-84.
24. Berghard A, Gradin K, Pongratz I, Whitelaw M, Poellinger L. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol Cell Biol 1993; 13: 677-89.
25. Kobayashi A, Numayama-Tsuruta K, Sogawa K, Fujii-Kuriyama Y. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocalor (Arnt). J Biochem (Tokyo) 1997; 122: 703-10.
26. Kobayashi A, Sogawa K, Fujii-Kuriyama Y. Cooperative interaction between AhR, Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene. J Biol Chem 1996; 271: 12310-6.
27. bis. Mimura J, Ema M, Sogawa K, Fuji-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 1999; 13: 20-5.
28. Duncan SA, Navas MA, Dufort D, Rossant J, Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281: 692-5.
29. Lahvis GP, Bradfield CA. Ahr null alleles: distinctive or different? Biochem Pharmacol 1998; 56: 781-7.
30. Gonzalez FJ, Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drus Metab Dispos 1998; 26: 1194-8.
31. -/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res 1997; 57: 2835-8.
32. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a marine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 1996; 93: 6731-6.
33. Mimura J, Yamashita K, Nakamura K, et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the An (dioxin) receptor. Genes Cells 1997; 2: 645-54.
34. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Arylhydrocarhon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxirol Appl Pharmacol 1996; 140: 173-9.
35. Sonnenfeld M, Ward M, Nystrom G, Mosher J, Stahl S, Crews S. The Drosophila tango gent encodes a bHLH-PAS protein that is orthologous to mammalian Arnt and controls CNS midline and tracheal development. Development 1997; 124: 4571-82.
36. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC,. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403-7.
37. Needham LL, Gerthoux PM, Patterson DG Jr, et al. Serum dioxin levels in Seveso, Italy, population in 1976. Teratogen Carcinog Mutagen 1997; 17: 225-40.
38. Pocchiari F, Silano V, Zampieri A. Human health effects from accidental release of tetrachlorodihenzo-p-dioxin (TCDD) at Seveso, Italy. Ann NY Acad Sci 1979; 320: 311-20.
39. Mocarelli P, Marocchi A, Brambilla P, Gerthoux P, Young DS, Mantel N. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 1986; 256: 2687-95.
40. Assennato G, Cervino D, Emmett EA, Longo G, Merlo F. Follow-up of subjects who developed chloracne following TCDD exposure at Seveso. AmJ Ind Med 1989; 16: 119-25.
41. Mocarelli P, Needham LL, Marocchi A, et al. Serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy. J Toxicol Environ Health 1991; 32: 357-66.
42. Mocarelli P, Brambilla P, Gerthoux PM, Patterson DG Jr, Needham LL. Change in sex ratio with exposure to dioxin. Lancet 1996; 348: 409.
43. Holsapple MP, Snyder NK, Wood SC, Morris DL. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 1991; 69: 219-55.
44. Neubert R, Golor G, Helge H, Neubert D. Risk assessment for possible effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related substances on components and functions of the immune system. Exp Clin Immunogenet 1994; 11 : 163-71.
45. Abraham K, Knoll A, Ende M, Papke O, Helge H. Intake, fecal excretion, and body burden of polychlorinated dibenzo-p-dioxins and dibenzofurans in breast-fed and formula-fed infants. Pediatr Res 1996; 40: 71-9.
46. Helge H. A pediatrician's view of studies on dioxin-attribuled effects in children. Toxicol Forum 1992: 272-81.
47. Steenland K, Pacitelli L. Deddens J, Fingerhut M, Chang L. Cancer, heart disease and diabetes in workers exposed to 2,3,7,8-tetrachloro-p-dioxin. J Natl Cancer Inst 1999; 91: 779-86.
48. Fujii-Kuriyama Y, Ema M, Mimura J, Matsushita N, Sogawa K. Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene. Pharmacogenetics 1995; 5: S149-53.
49. Poland A, Palen D, Glover E, Analysis of the four alleles of the marine aryl hydrocarbon. Mol Pharmacol 1994; 46: 915-21.